Table of Contents
Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. In addition to disease diagnosis, clinical lab testing is also performed to evaluate disease progression, monitor drug treatment and conditions, and determine individual therapy.
The global market for in vitro diagnostics (IVD) and clinical lab tests is strong, with a plethora of new products and rising procedure volumes through 2017. IVD Procedure Volumes and Pricing Analysis examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes. The report presents total global sales in 2014 of equipment, reagents and other products related to IVD and clinical laboratory tests.
Basic sales estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include:
Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other)
Core lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
Coagulation (PT, PTT)
Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
Pricing trend analysis is provided for each category. For each test type, estimates are provided for the historic 2014 period and forecasts are provided through 2019. Price estimates are offered for leading products, systems and equipment; these represent average list prices but do not take into account variations between countries, discounts or rebates and other fluctuations. Wherever possible, an attempt is made to present unit prices so that procedure volumes and trends may be more easily understood.
Trends that are contributing to strong and rising utilization of IVD and clinical lab tests are discussed. These include:
aging of the global population
high and rising incidence of disease
ongoing technology development and introduction of labor-saving systems
Diagnostic laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, automation, miniaturization and microelectronics as well as rapid development and proliferation of novel telecommunications technologies. IVD Procedure Volumes and Pricing Analysis is a unique business planning tool that tells readers which companies are performing what share of IVD procedures in this rapidly changing market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report:
Beckman Coulter, Inc./Danaher
Becton, Dickinson & Co.
Bio-RAD Laboratories, Inc.
Clarient, Inc./GE Healthcare
Laboratory Corporation of America
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...
Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt ...
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...